BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 1997
View Archived Issues
Novel antiangiogenic compounds from ADIR
Read More
Nissan Chemical discloses novel cardiovascular agents
Read More
Mitotix reports antiviral/anticancer antisense constructs
Read More
Novel human serine protease inhibitor for pancreatitis claimed by Incyte
Read More
T Cell Sciences describes anti-CETP vaccines
Read More
Anti-gp130 MAbs for inflammatory disorders and myeloma
Read More
Antidementia agents reported by Eisai
Read More
U.S. IND granted for Scotia's photodynamic drug
Read More
Pilocarpine TDS shows antiglaucoma activity in patients
Read More
University of Arizona researchers developing potential AD diagnostic
Read More
Lansoprazole equieffective to omeprazole in Dutch trial
Read More
Once-daily oral antibiotic from RPR cleared by FDA
Read More
Debate centers on the safety of coated aspirin
Read More
Immunomodulatory effects of ranitidine assessed in patient studies
Read More
Beacon signs Japanese licensing agreement for HIV and hepatitis tests
Read More
Company Profile: Cadila Pharmaceuticals
Read More
Hoechst establishes diagnostics company
Read More
Company Profile: Emisphere Technologies
Read More
Roche to acquire RPR consumer products
Read More
Crinone efficacy equal to that of higher doses of oral progesterone in IVF procedures
Read More
Novo Nordisk clear to market hGH product in U.S.
Read More
Osiris provides funds for clinical trial of hMSCs
Read More
Norian begins trial of Norian SRS in hip fractures
Read More
